PATENT CLAIM ANALYSIS

Application Number: 15987458
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["544", "237000"]

Abstract:
The present invention relates to a class of substituted triazolopiperazine compounds, tautomers, enantiomers, diastereomers, racemates, metabolites, metabolic precursors, and pharmaceutically acceptable salts, esters, prodrugs or hydrate thereof, a preparation methods therefor, intermediates and a use thereof in the preparation of drugs for prevention and treatment of diseases associated with PARP including various ischemic diseases, neurodegenerative diseases and cancers.

Claim (Index 5):
The substituted triazolopiperazine compound represented by formula (I) according to  claim 1 , tautomers, enantiomers, diastereomers, racemates, metabolites, metabolic precursors, pharmaceutically acceptable salts, esters, prodrugs or hydrates thereof,\n wherein, the substituted triazolopiperazine compound represented by formula (I) is selected from the follows: compound Structure S1   S2   S3   S4   S5   S6   S7   S8   S9   S10   S11   S12   S13   S14   S15   S16   S17   S18   S19   S20   S21   S22   S23   S24   S25   S26   S27   S28   S29   S30   S31   S32   S33   S34   S35   S36   S37   S38   S39

Metadata:
- Claim Count in Document: 9.0
- Percentile: 93.0
- Lexical Diversity: 1.44898
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14418705', '15708917', '13035640', '16060701', '11849230']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8103773342470209
- 35 USC 102 Novelty (BERT): 0.5491119005978518
- Combined Prediction Score: 0.7842507908821039
- Mean Citation Score: 337.94636
- Max Citation Score: 431.5869
- Similarity Product: 312.97856117727764

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test